ArticleTherapeutic advances in neurological disorders2024

Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study.

Ali A Habib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.